VRTX
Vertex Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$113.95B
P/E Ratio
29.32
EPS
$15.30
Beta
0.32
52W High
$510.77
52W Low
$362.50
50-Day MA
$469.18
200-Day MA
$438.51
Dividend Yield
—
Profit Margin
32.90%
Forward P/E
23.53
PEG Ratio
2.19
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $12.00B |
| Gross Profit (TTM) | $6.44B |
| EBITDA | $4.87B |
| Operating Margin | 39.60% |
| Return on Equity | 22.50% |
| Return on Assets | 12.20% |
| Revenue/Share (TTM) | $46.94 |
| Book Value | $73.49 |
| Price-to-Book | 6.11 |
| Price-to-Sales (TTM) | 9.49 |
| EV/Revenue | 9.11 |
| EV/EBITDA | 22.48 |
| Quarterly Earnings Growth (YoY) | 32.90% |
| Quarterly Revenue Growth (YoY) | 9.50% |
| Shares Outstanding | $254.00M |
| Float | $253.24M |
| % Insiders | 0.18% |
| % Institutions | 97.71% |
Historical Volatility
HV 10-Day
18.96%
HV 20-Day
40.50%
HV 30-Day
39.13%
HV 60-Day
34.77%
HV Rank
73.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($547.72 target)
4
Strong Buy21
Buy5
Hold1
Sell1
Strong SellData last updated: 3/25/2026